SCOTT WIENER: Open Payments
NPI 1922333996 · GREENFIELD, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526,242 in 730 payments from 9 companies in 2025. Trend: 2023 $292,715 · 2024 $282,824 · 2025 $526,242
Speaker / faculty: $258,750Honoraria: $130,106Travel & lodging: $108,198Food & beverage: $20,639Consulting: $8,550
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 366 | $285,576 |
| Axsome Therapeutics, Inc. | 207 | $157,194 |
| Neurocrine BioSciences, Inc. | 124 | $63,463 |
| Otsuka America Pharmaceutical, Inc. | 26 | $19,558 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $261 |
| Sage Therapeutics, LLC | 1 | $115 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Corium, LLC | 1 | $23 |
| Lundbeck LLC | 1 | $18 |
Products named: FANAPT, Auvelity, INGREZZA, REXULTI, ZURZUVAE, Qelbree, Azstarys.
Industry payments across WI — which companies pay providers there.
